Dutch DNA

What Dutch DNA does

Dutch DNA is a privately held, for-profit biotechnology research and development services company headquartered in Utrecht, the Netherlands. Founded in 2015, the firm operates with a workforce of 11-50 employees and is registered in the firmographic data as offering research and development activities related to biotechnology. The company's stated web presence is anchored at ddna-biotech.com. No further product, technology, customer, or revenue-model detail is provided in the source material, leaving the specific biotechnology focus areas (e.g., therapeutics, industrial biotech, agricultural biotech) and end markets undisclosed.

The documented corporate history consists of a single 2019 engagement with YES!Delft, a Dutch science and technology incubator, recorded at $0 in disclosed funding terms, which is consistent with incubator-stage non-equity or grant-style support rather than a priced equity financing. No subsequent funding rounds, strategic transactions, partnerships, product launches, leadership appointments, or geographic expansions are present in the input data. The firm has no identified parent company, subsidiaries, awards, patents, certifications, or public regulatory actions.

Public visibility is limited: the company maintains no documented social media profiles, app, or public investor-relations presence in the source set, and no management team or contact details are disclosed. As a result, Dutch DNA's competitive positioning, customer base, pricing, and financial performance cannot be triangulated from the available evidence; the analysis reflects an early-stage, low-public-footprint Dutch biotech services entity with a single confirmed 2019 incubator touchpoint.

Name

Dutch DNA

Legal name

Ginkgo Bioworks

Website

https://ddna-biotech.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Dutch DNA is a privately held biotechnology R&D services company headquartered in Utrecht, Netherlands, founded in 2015 with 11-50 employees, offering research and development activities in biotechnology.

Ownership category

akta.pro rank

Product category

Biotechnology R&D Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

mRNA/LNP & Nucleic Acid Therapeutics CDMO (HLAGABAF)

akta.pro secondary industries

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Process Development & Tech Transfer Services (CDMO) (HLAGABAL)

Keywords

• Biotechnology research
• Contract research
• Life sciences R&D
• Biotech development
• Scientific services

Headquarters

HQ city

Utrecht

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Autonomous Lab Sales: Selling autonomous lab infrastructure (hardware and software) to enterprises that want to build their own autonomous labs. Customers can purchase the full automation product including hardware, software, and support.
2. Cloud Lab / Solutions Services: Revenue from providing access to Ginkgo's autonomous lab remotely, including Ginkgo Solutions and Datapoints services for AI services, antibody developability, perturbation response profiling, small molecule developability, and high-throughput screening
3. Reagents: Sale of biological reagents through Ginkgo Reagents platform

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Dutch DNA provides research and development services related to biotechnology, supporting life sciences innovation for business clients. The company operates from its base in Utrecht, Netherlands, with a team of 11-50 employees engaged in biotechnology R&D activities.

Product overview

Ginkgo Bioworks is a biotechnology company operating a unified platform-plus-modules architecture built around autonomous laboratories. The core platform consists of Autonomous Labs that replace manual benchwork with robotic systems located at the Boston HQ, accessible via Cloud Lab for virtual experiment execution. The Automation Product provides the comprehensive hardware and software infrastructure for building and operating autonomous labs. Supporting modules include Hardware, Software, and Support services. The AI-powered service layer is anchored by Datapoints — which bundles Antibody Developability, Perturbation Response Profiling, Small Molecule Developability, and Specialized High-Throughput Screening — and the Catalyst Agent, an autonomous AI agent that enables scientists to interact with the lab using natural language. Additional offerings include Ginkgo Reagents (with a programmatic API), Applications (use case blueprints), and Solutions (consulting-led experiment design). The platform serves over 130 customers including pharmaceutical and biotechnology companies.

Differentiator

Problem solved

Functional benefit

Brands

• Ginkgo Reagents: Reagent products and services offered by Ginkgo Bioworks
• Ginkgo Datapoints
• Cloud Lab
• Grow by Ginkgo
• Ginkgo Ferment
• Catalyst Agent

Products and services

• Biotechnology R&D Services Research and development services related to biotechnology, delivered to business clients from the company's Utrecht, Netherlands location.

Quantifiable outcome

• 130+ customers across pharmaceutical, agricultural, and food ingredient industries trust Ginkgo's autonomous lab platform

Named customers9 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Scale indicators1 record

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• Catalent: Catalent is a global CDMO with deep capabilities in biologics, gene therapy, and nucleic acid formulation/fill-finish, serving large pharma similar to Dutch DNA's likely end-market. It is a comparable incumbent though operating at much larger scale.
• WuXi AppTec: WuXi AppTec offers comprehensive CRO/CDMO services spanning biologics, gene therapy, and nucleic acid manufacturing. It is comparable as a scaled services competitor in Dutch DNA's likely space, though geographically and structurally distinct.
• Lonza Group: Lonza is one of the world's largest CDMOs offering biologics, cell and gene therapy, and mRNA manufacturing services. It is comparable as the dominant scaled incumbent in Dutch DNA's likely service categories, though at vastly greater breadth and scale.
• Charles River Laboratories: Charles River is a major CRO/CDMO with biologics and gene therapy manufacturing services. Comparable as an incumbent offering overlapping biotech R&D and manufacturing services to pharma/biotech customers similar to Dutch DNA's likely buyers.

Direct peers

• Bio-Techne: Bio-Techne provides reagents, proteins, and gene-therapy/biologics tools and custom services, including nucleic-acid-related offerings. It is comparable to Dutch DNA as a specialized life-sciences services and tools provider focused on biotech R&D buyers.
• Cobra Biologics (Charles River): Cobra Biologics (now part of Charles River) is a specialist CDMO focused on viral vector, plasmid DNA, and nucleic acid services for gene therapy and cell therapy developers. It is a directly comparable European specialist in nucleic-acid CDMO services.
• GenScript: GenScript is a global biotech services company specializing in gene synthesis, plasmid/gRNA/mRNA manufacturing, and biologics development — directly comparable to a Dutch nucleic-acid-focused services firm in target customers (biopharma R&D) and core offering (DNA/RNA production and process development).

Others

• Sartorius AG: Sartorius is a German-headquartered bioprocessing and lab tools supplier enabling biotech and CDMO production workflows. It is comparable as an ecosystem enabler for nucleic-acid and biologics manufacturing rather than a direct services competitor.

Emerging players

• Touchlight DNA Services: Touchlight is a UK-based specialist in enzymatic DNA production for advanced therapies, with custom DNA manufacturing services. It is a comparable emerging specialist in the same nucleic-acid services niche Dutch DNA likely addresses.

Regional players

• Eurofins Scientific: Eurofins is a European-headquartered life-sciences testing and CDMO services group with strong presence in the Netherlands and broad nucleic-acid/genomics service offerings. It is a regional comparable with overlapping biotech services exposure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/Ginkgo
• Facebookfacebook.com/ginkgobioworks
• LinkedInlinkedin.com/company/ginkgo-bioworks

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dutch DNA